LALPATHLAB · Health Care · 2026-08-21
Dr. Lal PathLabs Ltd
6.5★★ GoodStrong +6.9Stage 2 · wk 11In scan: Breakout WatchMARKET: BULL RISING · 2026-08-21
₹1,894.2
+0.25% today
₹31,629 Cr · Large cap
About this companyHealth Care· Hospitals & Diagnostic CentresExpand ▾
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomist training programs. The company was founded in 1949 and is based in Gurugram, India.
Visit company website →P/E (TTM)
51.2
Forward 39.3
Earnings Growth (YoY)
-15.4%
Revenue +16.6%
ROE
+21.5%
Profit margin +18.3%
Dividend Yield
0.87%
P/B 11.3
vs 52W High
-3.8%
₹1,307.6 lo₹1,968.4 hi
3.8% below 52W high — pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 11
1w13w26w
Week 11 — early Stage 2, building
How long this stock has been in Stage 2. The sweet spot is typically 13–26 weeks — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
23.1%
200 DMA: ₹1,539.1 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.18x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↑
MA20 trending up · +5.7% vs MA50 +7.2%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
Stage 2%
55.5%
20d Δ
+3.9pp
1M return
+2.7%
3M return
+9.6%
Sector Stage-2 % · last 20 days
This stock ranks #43 of 84 Stage 2 stocks in Health Care by RS.
Industry
Hospitals & Diagnostic Centres
Stage 2%
55.6%
20d Δ
-7.4pp
1M return
-2.8%
3M return
+2.0%
Industry Stage-2 % · last 20 days
Ranks #6 of 15 Stage 2 stocks in this industry.
Price + Volume Chart
1M
+12.3%
3M
+16.2%
6M
+33.3%
YTD
+33.0%
1Y
+15.5%
Moving averages & range
50 DMA
₹1,765.8
200 DMA
₹1,539.1
52W High
₹1,968.4
52W Low
₹1,307.6
5D Low
₹1,877.3
Resistance levels (recent highs)
20d High
₹1,968.4
60d High
₹1,968.4
120d High
₹1,968.4
250d High
₹1,968.4
Next resistance
+3.9%
to 20d High
All analytics based on EOD data. Data as of 2026-08-21. Past data patterns are not indicative of future results. This page is a data analytics tool only.